Andrew Badrot, CEO, C2 Pharma.
Optimizing the Total Cost of Ownership for APIs
All members of the pharmaceutical supply chain must implement reliable sourcing and manufacturing strategies that balance quality and costs to ensure the uninterrupted supply of high-quality medicines to patients worldwide.